Recent Financing
Recent Raise
Abcuro is a clinical-stage biotechnology company developing immunotherapies that selectively target and deplete highly cytotoxic T cells to treat rare autoimmune diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
